Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections

Clin Infect Dis. 2021 Sep 15;73(6):1127-1128. doi: 10.1093/cid/ciab247.

Authors

Brandon Dionne^{1

2}, Todd C Lee^{3

4}

Affiliations

¹ School of Pharmacy, Northeastern University, Boston, Massachusetts, USA.
² Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.
⁴ Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada.

PMID: 33738497
DOI: 10.1093/cid/ciab247

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bacteremia* / drug therapy
Daptomycin* / therapeutic use
Humans
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections* / drug therapy
Vancomycin / therapeutic use

Substances

Vancomycin
Daptomycin